Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity
Background: Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide and the main cause of anticoagulation, being direct oral anticoagulants (DOAC) increasingly used in this context. On the other hand, obesity is a known risk thromboembolic factor. In the clinical trials that led to the a...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2021-12-01
|
| Ráidu: | International Journal of Cardiology: Heart & Vasculature |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2352906721002013 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|